WESPAC Advisors SoCal’s NxStage Medical Inc. NXTM Stock Holding History

WESPAC Advisors SoCal’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-750	Closed	-$21K	–	376
2018 Q4	$21K	Hold	750	–	–	0.01%	176
2018 Q3	$20K	Buy	+750	New	+$21.1K	0.01%	190
2018 Q2	–	Sell	-750	Closed	-$18K	–	285
2018 Q1	$18K	Hold	750	–	–	0.01%	173
2017 Q4	$18K	Hold	750	–	–	0.01%	164
2017 Q3	$20K	Hold	750	–	–	0.01%	168
2017 Q2	$18K	Hold	750	–	–	0.01%	163
2017 Q1	$20.1K	Hold	750	–	–	0.01%	153
2016 Q4	$19.7K	Hold	750	–	–	0.01%	151
2016 Q3	$18.7K	Hold	750	–	–	0.01%	153
2016 Q2	$16.3K	Buy	+750	New	+$13.4K	0.01%	170

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

WESPAC Advisors SoCal's NXTM Position: Q1 2019 in Review

WESPAC Advisors SoCal sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 750 shares — an estimated $21K sold.

WESPAC Advisors SoCal first reported a position in NXTM in Q2 2016 and held it in 10 quarters. The position peaked at $21K in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

WESPAC Advisors SoCal reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
WESPAC Advisors SoCal sold 750 NxStage Medical Inc. shares in Q1 2019, an estimated $21K.
WESPAC Advisors SoCal first reported a position in NxStage Medical Inc. in Q2 2016 and held it in 10 quarters.
WESPAC Advisors SoCal's NxStage Medical Inc. position peaked at $21K in Q4 2018.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on WESPAC Advisors SoCal's 13F filing for Q1 2019, filed 2 May 2019.